CALCIUM/CALMODULIN DEPENDENT KINASE 2 SIGNALING PATHWAY (PW:0001185)
Description
Calmodulin (CaM), the small and ubiquitous protein expressed from three identical genes in higher organisms, is the main cellular calcium (Ca2+) sensor. Important effectors are the calcium/calmodulin dependent protein kinases (CAMKs) and the only calcium/calmodulin dependent protein phosphatase calcineurin. Some CAMKs have unique targets while others are multifunctional, effectively orchestrating signaling pathways that exert many and important cellular functions. These pathways are represented by CAMK2 signaling and the CAMK1 and CAMK4 cascades. Of these, the CAMK2 exerts a plethora of functions. There are four Camk2 genes - alpha, beta, gamma, delta with distinct expression patterns. Alpha and beta are abundant in the brain while gamma and delta are expressed in many tissues but at comparatively lower levels with delta particularly abundant in the myocardium. The Camk2 signaling plays central roles in excitation-contraction (ECC) and excitation-transcription (E-T) coupling in the heart and in long-term potentiation (LTP) and memory in the brain. Along with the Camk1 cascade, it also plays important roles in cell cycle (not shown). Structurally, all genes are characterized by the presence of N-terminal catalytic domain, the internal regulatory domain that harbors the autoinhibitory segment, the Ca2+/CaM binding site and the critical threonine phosphorylation sites, and the C-terminal association domain also known as the hub; a variable length linker separates the regulatory and the hub regions. The variable length gives rise to more than 30 splice variants in mammals with differing responses to Ca2+ oscillations. The structure of the holoenzyme and of a calmodulin-bound delta isomer have been solved by X-ray crystallography and offer insights into the mechanisms of kinase activation. In the absence of Ca2+/CaM, the autoinhibitory segment forms a helix that block the substrate binding site. There is a compact overall arrangement of the holoenzyme complex; the N-terminal kinase domain is tethered to C-terminal association domain via the regulatory region organizing the protein into ring-shaped hexamers that form the dodecameric structure.
click to access the PDB page . The Ca2+/calmodulin/delta isoform complex contains the catalytic and regulatory domains of the enzyme. Within, the inhibitory region adopts an extended conformation, rather than helical while allowing for the interaction with an adjacent catalytic domain suggestive of an enzyme 'in transit' towards transphosphorylation.
Click to access the PDB page for the calmodulin-bound delta isoform . Binding of Ca2+/CaM displaces the inhibitory segment and the kinase autophosphorylates critical threonine (Thr) residues within the regulatory domain. Phosphorylation of Thr286/287 (286 in alpha, 287 in the other isoforms) dramatically increases the affinity of the kinase for Ca2+CaM and also renders the kinase active even after the Ca2+/Cam has dissociated, hence the autonomous, constitutive activity of Camk2. On the other hand, phosphorylation of Thr305/306 and Thr306/307 interfere with Ca2+CaM binding. These residues are within the Ca2+/CaM binding region; residues 296 and 316 in the enzyme are thought to be involved in the interaction with Ca2+/CaM. The three phosphorylation sites and the regulatory region are invariant across metazoans and there is a high degree of conservation for the hub residues involved in oligomerization. Reactive Oxygen Species (ROS) can activate the kinase in a Ca2+/CaM independent manner by modifying a pair of methionine (Met) residues within the regulatory domain which blocks its re-associatiation with the catalytic domain and preserves the active form of the kinase. The modification is viewed as a marker for oxidative stress and can be reversed by methionine sulfoxide reductases. Dephosphorylation and inactivation of Camk2 is carried out by many phosphatases; the Ca2+/CaM-dependent calcineurin does not directly dephosphorylate Camk2; it acts indirectly by inhibiting an inhibitor of a directly acting phosphatase. Two endogenous inhibitory proteins Camk2n1 and Camk2n2 have been identified in rodent brain and in human dendritic cells. They are specific for the active form of Camk2 and sterically inhibit the kinase; yet, the exact role they exert remains to be established.
In the heart, Camk2 targets many voltage-gated ion channels and excessive activation of the kinase can give rise to arrhythmia. Well established targets include the L-type Ca2+ channel Cacna1c (Cav1.2) and the regulatory beta2 subunit and the sodium channel Scn5a (Nav1.5). The sarcoplasmic reticulum (SR) ryanodine receptor Ryr2 and the regulator of Atp2a2 Ca2+ pump, phospholamban (Pln), are also targets. Camk2 promotes Ca2+ influx and release via Cav1.2 and Ryr2 while promoting Ca2+ uptake via Pln. Pln interacts with the SR pump and inhibits its function; phosphorylation relieves it and renders the pump active. Drugs that target the ion channels have been developed but they have powerful adverse effects. A splice variant of delta gene contains a nuclear localization signal; nuclear targets of Camk2d are histone deacetylases Hdac4 and 5, with the former being the preferred substrate. In the dephosphorylated state, the two bind and repress hypertrophic transcription factors such as Mef2. Phosphorylation relives the repression, allowing for the activation of Mef2-dependent transcription.
The two abundant neuronal subunits of Camk2 are alpha and beta that in addition to homomers, also form heteromers . Activated Camk2 translocates from the cytoplasm to the synapse and interacts with proteins in the postsynaptic density (PSD); a prominent member is Grin2b (NR2B) subtype of ionotropic NMDA receptor. While Camk2 can bind other PSD members, the interaction with Grin2b appears to be crucial for the synaptic translocation of the kinase. This places Camk2 in proximity of ionotropic AMPA receptor Gria1 and stargazin (Cacng2) - a gamma subunit of L-type Ca2+ channel and an auxiliary subunit of AMPA. The phosphorylation of these two substrates enhances the conductance of AMPA receptor and concomitantly leads to the trafficking of additional ones, respectively. These events provide a mechanistic explanation of the early LTP phase. The later phases and LTP maintenance and the exact role Camk2 plays, are far less well understood. Possibly, the binding reactions of Camk2 rather than its catalytic activity are important. Phosphorylation of Thr205/306 may underlie the role of Camk2 in long term depression (LTD), also a feature of the excitatory synapse. To see the ontology report for annotations, Gviewer and download, click here ....(less)
Pathway Diagram:
Genes in Pathway:
G
Cacna1c
calcium channel, voltage-dependent, L type, alpha 1C subunit
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr 6:118,564,201...119,174,345
Ensembl chr 6:118,564,201...119,173,851
G
Cacnb2
calcium channel, voltage-dependent, beta 2 subunit
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr 2:14,608,672...14,993,622
Ensembl chr 2:14,607,899...14,992,719
G
Cacng2
calcium channel, voltage-dependent, gamma subunit 2
ISO
RGD
PMID:22334212
RGD:7240704
NCBI chr15:77,876,119...78,004,420
Ensembl chr15:77,875,948...78,004,228
G
Calm1
calmodulin 1
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr12:100,165,694...100,176,083
Ensembl chr12:100,165,694...100,176,073
G
Calm2
calmodulin 2
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr17:87,740,829...87,754,363
Ensembl chr17:87,740,840...87,754,363
G
Calm3
calmodulin 3
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr 7:16,649,304...16,657,957
Ensembl chr 7:16,649,304...16,658,039
G
Camk2a
calcium/calmodulin-dependent protein kinase II alpha
ISO
RGD
PMID:22334212 PMID:22717267
RGD:7240704 , RGD:7240705
NCBI chr18:61,058,704...61,121,224
Ensembl chr18:61,058,690...61,121,224
G
Camk2b
calcium/calmodulin-dependent protein kinase II, beta
ISO
RGD
PMID:22334212 PMID:22717267
RGD:7240704 , RGD:7240705
NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362
G
Camk2d
calcium/calmodulin-dependent protein kinase II, delta
ISO
RGD
PMID:22717267 PMID:23091085
RGD:7240705 , RGD:7240708
NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr14:20,784,943...20,844,225
Ensembl chr14:20,784,943...20,844,156
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
ISO
RGD
PMID:21070840 PMID:21301225
RGD:7240706 , RGD:7240707
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Camk2n2
calcium/calmodulin-dependent protein kinase II inhibitor 2
ISO
RGD
PMID:21070840 PMID:21301225
RGD:7240706 , RGD:7240707
NCBI chr16:20,437,965...20,440,028
Ensembl chr16:20,437,965...20,440,037
G
Dlg1
discs large MAGUK scaffold protein 1
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr16:31,482,261...31,692,174
Ensembl chr16:31,482,261...31,693,947
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
ISO
RGD
PMID:22334212
RGD:7240704
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Grin2a
glutamate receptor, ionotropic, NMDA2A (epsilon 1)
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
G
Grin2b
glutamate receptor, ionotropic, NMDA2B (epsilon 2)
ISO
RGD
PMID:22334212 PMID:22717267
RGD:7240704 , RGD:7240705
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
G
Hdac4
histone deacetylase 4
ISO
RGD
PMID:21255680
RGD:7241019
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
G
Hdac5
histone deacetylase 5
ISO
RGD
PMID:21255680
RGD:7241019
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
G
Lrrc7
leucine rich repeat containing 7
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr 3:157,772,823...158,268,254
Ensembl chr 3:157,788,528...158,267,858 Ensembl chr 3:157,788,528...158,267,858
G
Pln
phospholamban
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr10:53,213,782...53,222,095
Ensembl chr10:53,213,763...53,222,083
G
Ppm1e
protein phosphatase 1E (PP2C domain containing)
ISO
RGD
PMID:18454172
RGD:7241020
NCBI chr11:87,117,724...87,249,884
Ensembl chr11:87,117,732...87,249,849
G
Ppm1f
protein phosphatase 1F (PP2C domain containing)
ISO
RGD
PMID:18454172
RGD:7241020
NCBI chr16:16,714,314...16,745,239
Ensembl chr16:16,714,333...16,745,228
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
ISO
RGD
PMID:18454172
RGD:7241020
NCBI chr 5:122,296,338...122,313,336
Ensembl chr 5:122,296,341...122,313,336
G
Ppp2ca
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
ISO
RGD
PMID:18454172
RGD:7241020
NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
G
Ryr2
ryanodine receptor 2, cardiac
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr13:11,567,985...12,121,831
Ensembl chr13:11,567,988...12,121,831
G
Scn5a
sodium channel, voltage-gated, type V, alpha
ISO
RGD
PMID:23091085
RGD:7240708
NCBI chr 9:119,312,470...119,408,096
Ensembl chr 9:119,312,474...119,408,082
G
Syngap1
synaptic Ras GTPase activating protein 1 homolog (rat)
ISO
RGD
PMID:22717267
RGD:7240705
NCBI chr17:27,160,186...27,191,408
Ensembl chr17:27,160,227...27,191,408
Pathway Gene Annotations
Disease Annotations Associated with Genes in the calcium/calmodulin dependent kinase 2 signaling pathway
Cacna1c acute stress disorder , alcohol dependence , Alzheimer's disease , amyloidosis , anxiety disorder , arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , autistic disorder , bipolar disorder , breast ductal carcinoma , Brugada syndrome , Brugada syndrome 3 , Cardiac Arrhythmias , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , cerebral palsy , Cognitive Dysfunction , Congenital Limb Deformities , congestive heart failure , dilated cardiomyopathy , epilepsy , esophageal atresia , Familial Ventricular Tachycardia , Fetal Growth Retardation , genetic disease , Genetic Predisposition to Disease , Heart Block , Hyperphosphatemic Familial Tumoral Calcinosis 1 , hypertension , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypoglycemia , intellectual disability , invasive ductal carcinoma , Joint Instability , Language Development Disorders , long QT syndrome , long QT syndrome 1 , long QT syndrome 8 , major depressive disorder , neurodevelopmental disorder with dysmorphic facies and distal limb anomalies , neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures , Neurodevelopmental Disorders , post-traumatic stress disorder , primary immunodeficiency disease , Psychomotor Agitation , pulmonary valve stenosis , restrictive cardiomyopathy , Romano-Ward Syndrome , schizophrenia , short QT syndrome , Sudden Cardiac Death , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Timothy syndrome , Tremor , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Cacnb2 arrhythmogenic right ventricular cardiomyopathy , autism spectrum disorder , Brugada syndrome , Brugada syndrome 4 , cardiac arrest , Cardiac Arrhythmias , cardiomyopathy , dilated cardiomyopathy , heart conduction disease , hypertension , hypertrophic cardiomyopathy , hypoparathyroidism-deafness-renal disease syndrome , Imerslund-Grasbeck Syndrome , long QT syndrome , Nerve Injuries , Paroxysmal Ventricular Fibrillation , short QT syndrome , Sudden Death , Sudden Unexpected Nocturnal Death Syndrome , Supraventricular Tachycardia , Ventricular Fibrillation , Ventricular Tachycardia Cacng2 adenylosuccinase lyase deficiency , autosomal dominant intellectual developmental disorder 10 , childhood absence epilepsy , epilepsy , high grade glioma , Neurodevelopmental Disorders Calm1 achondrogenesis type IA , Alzheimer's disease , cannabis abuse , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , catecholaminergic polymorphic ventricular tachycardia 4 , Cocaine-Related Disorders , Familial Ventricular Tachycardia , long QT syndrome , long QT syndrome 14 , phencyclidine abuse , type 2 diabetes mellitus , Weight Gain Calm2 cannabis abuse , Cocaine-Related Disorders , COVID-19 , genetic disease , long QT syndrome , long QT syndrome 1 , long QT syndrome 15 , Lynch syndrome , major depressive disorder , multiple intestinal atresia , phencyclidine abuse , sudden infant death syndrome Calm3 familial hypertrophic cardiomyopathy , long QT syndrome , long QT syndrome 1 , long QT syndrome 16 , Walker-Warburg syndrome Camk2a Alzheimer's disease , autism spectrum disorder , autosomal dominant intellectual developmental disorder 53 , autosomal recessive intellectual developmental disorder 63 , bipolar disorder , Cocaine-Related Disorders , Developmental Disabilities , familial adenomatous polyposis 1 , genetic disease , Hearing Loss, Cisplatin-Induced , Hepatomegaly , Hereditary Neoplastic Syndromes , high grade glioma , Hyperalgesia , Inflammation , intellectual disability , Larsen syndrome , middle cerebral artery infarction , mitochondrial metabolism disease , nephrotoxicity , Neurodevelopmental Disorders , transient cerebral ischemia , Wilson disease Camk2b Apnea , autism spectrum disorder , autosomal dominant intellectual developmental disorder 54 , cannabis abuse , Cocaine-Related Disorders , Developmental Disabilities , Developmental Disease , dystonia , genetic disease , Hearing Loss, Cisplatin-Induced , high grade glioma , Hyperventilation , intellectual disability , microcephaly , Nervous System Malformations , Neurodevelopmental Disorders , oligodendroglioma , phencyclidine abuse , pleomorphic xanthoastrocytoma , schizophrenia , substance-induced psychosis Camk2d aniridia , atrial fibrillation , Cardiomegaly , epilepsy , Experimental Liver Cirrhosis , myocardial infarction , Myocardial Ischemia , Neurodevelopmental Disorders , polycystic ovary syndrome , renovascular hypertension Camk2g autistic disorder , Autosomal Dominant Intellectual Developmental Disorder 59 , intellectual disability , malignant astrocytoma , Neurodevelopmental Disorders Camk2n1 3-hydroxy-3-methylglutaryl-CoA lyase deficiency , alcohol use disorder , congenital disorder of glycosylation Ir , COVID-19 , Drug-Related Side Effects and Adverse Reactions , hepatocellular carcinoma , hyperprolinemia type 2 , Japanese encephalitis , oral squamous cell carcinoma , ovarian cancer , ovarian carcinoma , papillary thyroid carcinoma , Parkinson's disease 6 , prostate adenocarcinoma , prostate cancer , rabies Camk2n2 3-methylcrotonyl-CoA carboxylase 1 deficiency , congenital disorder of glycosylation Id , Currarino syndrome Dlg1 autistic disorder , cervix uteri carcinoma in situ , chromosome 3q29 microdeletion syndrome , cleft palate , invasive ductal carcinoma , Parkinson's disease , schizophrenia Gria1 alcohol dependence , alcohol use disorder , alcohol withdrawal syndrome , allergic rhinitis , amphetamine abuse , autism spectrum disorder , autistic disorder , Autosomal Dominant Intellectual Developmental Disorder 67 , autosomal recessive intellectual developmental disorder 76 , Central Nervous System Viral Diseases , cocaine abuse , cocaine dependence , Cocaine-Related Disorders , cognitive disorder , depressive disorder , epilepsy , familial adenomatous polyposis 1 , Fetal Growth Retardation , genetic disease , hepatic encephalopathy , Hereditary Neoplastic Syndromes , heroin dependence , Hyperalgesia , hyperhomocysteinemia , Hyperkinesis , Hypotension , intellectual disability , learning disability , morphine dependence , morphine withdrawal syndrome , Neurodevelopmental Disorders , non-syndromic intellectual disability , Olfaction Disorders , Reperfusion Injury , schizoaffective disorder , sexual health disorder , status epilepticus , traumatic brain injury , visual epilepsy , withdrawal disorder Grin1 Adams-Oliver Syndrome 5 , alcohol use disorder , Alzheimer's disease , Animal Disease Models , autism spectrum disorder , autistic disorder , autosomal dominant intellectual developmental disorder 8 , autosomal dominant nocturnal frontal lobe epilepsy 5 , benign epilepsy with centrotemporal spikes , Brain Hypoxia-Ischemia , cerebral infarction , Cocaine-Related Disorders , cognitive disorder , developmental and epileptic encephalopathy 1 , developmental and epileptic encephalopathy 101 , developmental and epileptic encephalopathy 14 , Developmental Disabilities , epilepsy , Experimental Diabetes Mellitus , Febrile Seizures , genetic disease , Hemimegalencephaly , Hyperalgesia , intellectual disability , Joubert syndrome 1 , Kleefstra syndrome 1 , Language Development Disorders , Leigh disease , Macrocephaly , middle cerebral artery infarction , morphine dependence , Neurodevelopmental Disorder with or without Hyperkinetic Movements and Seizures, Autosomal Recessive , Neurodevelopmental Disorders , opioid abuse , Pain , placental insufficiency , primary coenzyme Q10 deficiency 7 , prostate cancer , psychotic disorder , Rafiq syndrome , schizophrenia , sciatic neuropathy , status epilepticus , trigeminal neuralgia , tuberous sclerosis 1 , vascular dementia Grin2a alcohol dependence , Alzheimer's disease , autistic disorder , autosomal dominant intellectual developmental disorder 21 , benign epilepsy with centrotemporal spikes , bipolar disorder , Brain Hypoxia-Ischemia , Central Nervous System Viral Diseases , Charcot-Marie-Tooth disease type 1C , cognitive disorder , colorectal cancer , Colorectal Neoplasms , developmental and epileptic encephalopathy 11 , Developmental Disabilities , epilepsy , familial temporal lobe epilepsy 1 , Fetal Growth Retardation , focal epilepsy , Focal Epilepsy with Speech Disorder and with or without Mental Retardation , GABA aminotransferase deficiency , Generalized Epilepsy , genetic disease , heroin dependence , Huntington's disease , Hyperalgesia , hyperhomocysteinemia , intellectual disability , Landau-Kleffner syndrome , Language Development Disorders , melanoma , MHC class II deficiency , microcephaly , morphine dependence , nasopharynx carcinoma , neonatal abstinence syndrome , Neuralgia , NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES , Neurodevelopmental Disorders , opioid abuse , placental insufficiency , post-traumatic stress disorder , pyridoxine-dependent epilepsy , Reperfusion Injury , schizophrenia , Sepsis , speech disorder , status epilepticus , Tinnitus , transient cerebral ischemia , vascular dementia , withdrawal disorder Grin2b alcohol use disorder , Alzheimer's disease , astigmatism , Ataxia , attention deficit hyperactivity disorder , autism spectrum disorder , autistic disorder , autosomal dominant intellectual developmental disorder , autosomal dominant intellectual developmental disorder 6 , bipolar disorder , Brain Hypoxia-Ischemia , cerebral palsy , chronic obstructive pulmonary disease , cognitive disorder , Craniosynostosis Syndrome, Autosomal Recessive , developmental and epileptic encephalopathy 11 , developmental and epileptic encephalopathy 27 , Developmental Disabilities , Developmental Disease , dystonia , egg allergy , epilepsy , Experimental Diabetes Mellitus , fetal alcohol spectrum disorder , Fetal Growth Retardation , Generalized Epilepsy , genetic disease , Huntington's disease , Hyperalgesia , hyperhomocysteinemia , hypoglycemia , Hypotension , Hypoxia , intellectual disability , Landau-Kleffner syndrome , Nervous System Trauma , Neurodevelopmental Disorders , nicotine dependence , opioid abuse , phenylketonuria , placental insufficiency , Reperfusion Injury , retinitis pigmentosa , schizophrenia , sciatic neuropathy , Sleep Deprivation , temporal lobe epilepsy , transient cerebral ischemia , vascular dementia , withdrawal disorder Hdac4 acute lymphoblastic leukemia , amyotrophic lateral sclerosis , aortic aneurysm , ataxia telangiectasia , atherosclerosis , Bethlem Myopathy 1A , brachydactyly , brachydactyly type E1 , Brachydactyly, Type E , Carotid Artery Injuries , chromosome 2q37 deletion syndrome , Cocaine-Related Disorders , contact dermatitis , D-2-hydroxyglutaric aciduria 1 , Diabetes Complications , Diabetic Nephropathies , eating disorder , Experimental Diabetes Mellitus , fetal alcohol spectrum disorder , Fibrosis , genetic disease , hepatocellular carcinoma , hereditary spastic paraplegia 30 , Hypoalgesia , impotence , intellectual disability , malignant mesothelioma , microcephaly , middle cerebral artery infarction , multiple myeloma , NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES , Neurodevelopmental Disorders , obesity , primary hyperoxaluria type 1 , primary pulmonary hypertension , pulmonary hypertension , retinal degeneration , Sepsis , spinal muscular atrophy , Stroke , syndromic intellectual disability , urinary bladder cancer , visual epilepsy Hdac5 acute kidney failure , adjustment disorder , bipolar disorder , Cocaine-Related Disorders , colorectal cancer , depressive disorder , Diabetic Nephropathies , GRN-related frontotemporal lobar degeneration with TDP43 inclusions , hereditary breast ovarian cancer syndrome , middle cerebral artery infarction , primary pulmonary hypertension , pulmonary hypertension , Right Ventricular Hypertrophy , systemic scleroderma Lrrc7 cocaine dependence , Cocaine-Related Disorders , intellectual disability Pln atrial fibrillation , autistic disorder , cardiac arrest , cardiomyopathy , centronuclear myopathy , congenital disorder of glycosylation Iaa , congestive heart failure , Diabetes Complications , Diabetic Cardiomyopathies , dilated cardiomyopathy , dilated cardiomyopathy 1P , Ebstein anomaly , epilepsy , heart disease , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 18 , intellectual disability , intrinsic cardiomyopathy , lissencephaly 10 , microcephaly , myocardial infarction , Myocardial Reperfusion Injury , myocardial stunning , Prehypertension , Sudden Cardiac Death , Tremor , type 2 diabetes mellitus , Ventricular Dysfunction, Left Ppm1e Colorectal Neoplasms , Joubert syndrome 1 , mulibrey nanism Ppm1f chromosome 22q11.2 deletion syndrome, distal , DiGeorge syndrome Ppp1cc congestive heart failure , Ovarian Neoplasms , Spinal Cord Injuries Ppp2ca asthma , congestive heart failure , Experimental Liver Neoplasms , familial adenomatous polyposis 1 , genetic disease , heart disease , Hereditary Neoplastic Syndromes , Hyperalgesia , Myocardial Ischemia , Neurodevelopmental Disorder and Language Delay with or Without Structural Brain Abnormalities , Neurodevelopmental Disorders , Parkinson's disease , prostate cancer , type 2 diabetes mellitus Ryr2 arrhythmogenic right ventricular cardiomyopathy , arrhythmogenic right ventricular dysplasia 1 , arrhythmogenic right ventricular dysplasia 9 , autism spectrum disorder , Brugada syndrome , cardiac arrest , Cardiac Arrhythmias , Cardiac Conduction Defect , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , catecholaminergic polymorphic ventricular tachycardia 2 , Childhood Schizophrenia , congenital heart disease , congestive heart failure , coronary artery disease , Diabetic Cardiomyopathies , Diastolic Dysfunction , dilated cardiomyopathy , dilated cardiomyopathy 1AA , dilated cardiomyopathy 1B , Dilated Cardiomyopathy with Left Ventricular Noncompaction , Experimental Diabetes Mellitus , familial hypertrophic cardiomyopathy , Familial Sudden Death , Familial Ventricular Tachycardia , gastrointestinal stromal tumor , gestational diabetes , Heart Block , heart disease , Hereditary Leiomyomatosis and Renal Cell Cancer , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , hypertrophic cardiomyopathy 4 , Infant Death , Leber congenital amaurosis , left ventricular noncompaction , long QT syndrome , long QT syndrome 1 , malignant mesothelioma , Myocardial Ischemia , parathyroid carcinoma , Paroxysmal Ventricular Fibrillation , pre-eclampsia , pulmonary hypertension , Sudden Cardiac Death , Sudden Death , Syncope , Tachycardia , Ventricular Fibrillation , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Wolff-Parkinson-White syndrome Scn5a arrhythmogenic right ventricular cardiomyopathy , atrial fibrillation , atrial standstill 1 , atrioventricular block , autistic disorder , brain ischemia , Brugada syndrome , Brugada syndrome 1 , cardiac arrest , Cardiac Arrhythmias , Cardiac Conduction Defect , Cardiac Conduction Defect, Nonprogressive , Cardiac Conduction Defect, Nonspecific , cardiomyopathy , catecholaminergic polymorphic ventricular tachycardia , catecholaminergic polymorphic ventricular tachycardia 1 , congestive heart failure , Death , dilated cardiomyopathy , dilated cardiomyopathy 1A , dilated cardiomyopathy 1B , dilated cardiomyopathy 1E , dilated cardiomyopathy 1H , Dilated Cardiomyopathy with Left Ventricular Noncompaction , Familial Atrial Fibrillation 10 , familial hypertrophic cardiomyopathy , fetal akinesia deformation sequence syndrome 1 , genetic disease , Heart Block , heart conduction disease , hemiplegia , hereditary sensory and autonomic neuropathy type 7 , hypertrophic cardiomyopathy , hypertrophic cardiomyopathy 1 , Immunodeficiency 68 , Infant Death , Left Ventricular Noncompaction 1 , long QT syndrome , long QT syndrome 1 , long QT syndrome 2 , Long QT Syndrome 2/3 , long QT syndrome 3 , Long QT Syndrome 3/6 , migraine , Nonprogressive Heart Block , Paroxysmal Ventricular Fibrillation , progressive familial heart block , Progressive Familial Heart Block Type I , progressive familial heart block type IA , Romano-Ward Syndrome , sick sinus syndrome , Sick Sinus Syndrome 1, Autosomal Recessive , sinoatrial node disease , Sudden Cardiac Death , Sudden Death , sudden infant death syndrome , Sudden Unexpected Nocturnal Death Syndrome , Syncope , Torsades de Pointes , Ventricular Fibrillation , Ventricular Fibrillation, Paroxysmal Familial, 1 , Ventricular Tachycardia , Visceral Heterotaxy 4, Autosomal , Wolff-Parkinson-White syndrome Syngap1 autistic disorder , autosomal dominant intellectual developmental disorder 5 , autosomal dominant nocturnal frontal lobe epilepsy , autosomal recessive intellectual developmental disorder 5 , cerebellar ataxia , developmental and epileptic encephalopathy 11 , Developmental Disabilities , Developmental Disease , epilepsy , Generalized Epilepsy , genetic disease , intellectual disability , Marfanoid Mental Retardation Syndrome, Autosomal , MHC class I deficiency , Neurodevelopmental Disorders , proteasome-associated autoinflammatory syndrome 1 , ptosis , salt and pepper syndrome , schizophrenia
3-hydroxy-3-methylglutaryl-CoA lyase deficiency Camk2n1 3-methylcrotonyl-CoA carboxylase 1 deficiency Camk2n2 achondrogenesis type IA Calm1 acute kidney failure Hdac5 acute lymphoblastic leukemia Hdac4 acute stress disorder Cacna1c Adams-Oliver Syndrome 5 Grin1 adenylosuccinase lyase deficiency Cacng2 adjustment disorder Hdac5 alcohol dependence Cacna1c , Gria1 , Grin2a alcohol use disorder Camk2n1 , Gria1 , Grin1 , Grin2b alcohol withdrawal syndrome Gria1 allergic rhinitis Gria1 Alzheimer's disease Cacna1c , Calm1 , Camk2a , Grin1 , Grin2a , Grin2b amphetamine abuse Gria1 amyloidosis Cacna1c amyotrophic lateral sclerosis Hdac4 Animal Disease Models Grin1 aniridia Camk2d anxiety disorder Cacna1c aortic aneurysm Hdac4 Apnea Camk2b arrhythmogenic right ventricular cardiomyopathy Cacna1c , Cacnb2 , Ryr2 , Scn5a arrhythmogenic right ventricular dysplasia 1 Ryr2 arrhythmogenic right ventricular dysplasia 9 Ryr2 asthma Ppp2ca astigmatism Grin2b Ataxia Grin2b ataxia telangiectasia Hdac4 atherosclerosis Hdac4 atrial fibrillation Camk2d , Pln , Scn5a atrial standstill 1 Scn5a atrioventricular block Scn5a attention deficit hyperactivity disorder Grin2b autism spectrum disorder Cacna1c , Cacnb2 , Camk2a , Camk2b , Gria1 , Grin1 , Grin2b , Ryr2 autistic disorder Cacna1c , Camk2g , Dlg1 , Gria1 , Grin1 , Grin2a , Grin2b , Pln , Scn5a , Syngap1 autosomal dominant intellectual developmental disorder Grin2b autosomal dominant intellectual developmental disorder 10 Cacng2 autosomal dominant intellectual developmental disorder 21 Grin2a autosomal dominant intellectual developmental disorder 5 Syngap1 autosomal dominant intellectual developmental disorder 53 Camk2a autosomal dominant intellectual developmental disorder 54 Camk2b Autosomal Dominant Intellectual Developmental Disorder 59 Camk2g autosomal dominant intellectual developmental disorder 6 Grin2b Autosomal Dominant Intellectual Developmental Disorder 67 Gria1 autosomal dominant intellectual developmental disorder 8 Grin1 autosomal dominant nocturnal frontal lobe epilepsy Syngap1 autosomal dominant nocturnal frontal lobe epilepsy 5 Grin1 autosomal recessive intellectual developmental disorder 5 Syngap1 autosomal recessive intellectual developmental disorder 63 Camk2a autosomal recessive intellectual developmental disorder 76 Gria1 benign epilepsy with centrotemporal spikes Grin1 , Grin2a Bethlem Myopathy 1A Hdac4 bipolar disorder Cacna1c , Camk2a , Grin2a , Grin2b , Hdac5 brachydactyly Hdac4 brachydactyly type E1 Hdac4 Brachydactyly, Type E Hdac4 Brain Hypoxia-Ischemia Grin1 , Grin2a , Grin2b brain ischemia Scn5a breast ductal carcinoma Cacna1c Brugada syndrome Cacna1c , Cacnb2 , Ryr2 , Scn5a Brugada syndrome 1 Scn5a Brugada syndrome 3 Cacna1c Brugada syndrome 4 Cacnb2 cannabis abuse Calm1 , Calm2 , Camk2b cardiac arrest Cacnb2 , Pln , Ryr2 , Scn5a Cardiac Arrhythmias Cacna1c , Cacnb2 , Ryr2 , Scn5a Cardiac Conduction Defect Ryr2 , Scn5a Cardiac Conduction Defect, Nonprogressive Scn5a Cardiac Conduction Defect, Nonspecific Scn5a Cardiomegaly Camk2d cardiomyopathy Cacna1c , Cacnb2 , Pln , Ryr2 , Scn5a Carotid Artery Injuries Hdac4 catecholaminergic polymorphic ventricular tachycardia Cacna1c , Calm1 , Ryr2 , Scn5a catecholaminergic polymorphic ventricular tachycardia 1 Calm1 , Ryr2 , Scn5a catecholaminergic polymorphic ventricular tachycardia 2 Ryr2 catecholaminergic polymorphic ventricular tachycardia 4 Calm1 Central Nervous System Viral Diseases Gria1 , Grin2a centronuclear myopathy Pln cerebellar ataxia Syngap1 cerebral infarction Grin1 cerebral palsy Cacna1c , Grin2b cervix uteri carcinoma in situ Dlg1 Charcot-Marie-Tooth disease type 1C Grin2a childhood absence epilepsy Cacng2 Childhood Schizophrenia Ryr2 chromosome 22q11.2 deletion syndrome, distal Ppm1f chromosome 2q37 deletion syndrome Hdac4 chromosome 3q29 microdeletion syndrome Dlg1 chronic obstructive pulmonary disease Grin2b cleft palate Dlg1 cocaine abuse Gria1 cocaine dependence Gria1 , Lrrc7 Cocaine-Related Disorders Calm1 , Calm2 , Camk2a , Camk2b , Gria1 , Grin1 , Hdac4 , Hdac5 , Lrrc7 cognitive disorder Gria1 , Grin1 , Grin2a , Grin2b Cognitive Dysfunction Cacna1c colorectal cancer Grin2a , Hdac5 Colorectal Neoplasms Grin2a , Ppm1e congenital disorder of glycosylation Iaa Pln congenital disorder of glycosylation Id Camk2n2 congenital disorder of glycosylation Ir Camk2n1 congenital heart disease Ryr2 Congenital Limb Deformities Cacna1c congestive heart failure Cacna1c , Pln , Ppp1cc , Ppp2ca , Ryr2 , Scn5a contact dermatitis Hdac4 coronary artery disease Ryr2 COVID-19 Calm2 , Camk2n1 Craniosynostosis Syndrome, Autosomal Recessive Grin2b Currarino syndrome Camk2n2 D-2-hydroxyglutaric aciduria 1 Hdac4 Death Scn5a depressive disorder Gria1 , Hdac5 developmental and epileptic encephalopathy 1 Grin1 developmental and epileptic encephalopathy 101 Grin1 developmental and epileptic encephalopathy 11 Grin2a , Grin2b , Syngap1 developmental and epileptic encephalopathy 14 Grin1 developmental and epileptic encephalopathy 27 Grin2b Developmental Disabilities Camk2a , Camk2b , Grin1 , Grin2a , Grin2b , Syngap1 Developmental Disease Camk2b , Grin2b , Syngap1 Diabetes Complications Hdac4 , Pln Diabetic Cardiomyopathies Pln , Ryr2 Diabetic Nephropathies Hdac4 , Hdac5 Diastolic Dysfunction Ryr2 DiGeorge syndrome Ppm1f dilated cardiomyopathy Cacna1c , Cacnb2 , Pln , Ryr2 , Scn5a dilated cardiomyopathy 1A Scn5a dilated cardiomyopathy 1AA Ryr2 dilated cardiomyopathy 1B Ryr2 , Scn5a dilated cardiomyopathy 1E Scn5a dilated cardiomyopathy 1H Scn5a dilated cardiomyopathy 1P Pln Dilated Cardiomyopathy with Left Ventricular Noncompaction Ryr2 , Scn5a Drug-Related Side Effects and Adverse Reactions Camk2n1 dystonia Camk2b , Grin2b eating disorder Hdac4 Ebstein anomaly Pln egg allergy Grin2b epilepsy Cacna1c , Cacng2 , Camk2d , Gria1 , Grin1 , Grin2a , Grin2b , Pln , Syngap1 esophageal atresia Cacna1c Experimental Diabetes Mellitus Grin1 , Grin2b , Hdac4 , Ryr2 Experimental Liver Cirrhosis Camk2d Experimental Liver Neoplasms Ppp2ca familial adenomatous polyposis 1 Camk2a , Gria1 , Ppp2ca Familial Atrial Fibrillation 10 Scn5a familial hypertrophic cardiomyopathy Calm3 , Ryr2 , Scn5a Familial Sudden Death Ryr2 familial temporal lobe epilepsy 1 Grin2a Familial Ventricular Tachycardia Cacna1c , Calm1 , Ryr2 Febrile Seizures Grin1 fetal akinesia deformation sequence syndrome 1 Scn5a fetal alcohol spectrum disorder Grin2b , Hdac4 Fetal Growth Retardation Cacna1c , Gria1 , Grin2a , Grin2b Fibrosis Hdac4 focal epilepsy Grin2a Focal Epilepsy with Speech Disorder and with or without Mental Retardation Grin2a GABA aminotransferase deficiency Grin2a gastrointestinal stromal tumor Ryr2 Generalized Epilepsy Grin2a , Grin2b , Syngap1 genetic disease Cacna1c , Calm2 , Camk2a , Camk2b , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Ppp2ca , Scn5a , Syngap1 Genetic Predisposition to Disease Cacna1c gestational diabetes Ryr2 GRN-related frontotemporal lobar degeneration with TDP43 inclusions Hdac5 Hearing Loss, Cisplatin-Induced Camk2a , Camk2b Heart Block Cacna1c , Ryr2 , Scn5a heart conduction disease Cacnb2 , Scn5a heart disease Pln , Ppp2ca , Ryr2 Hemimegalencephaly Grin1 hemiplegia Scn5a hepatic encephalopathy Gria1 hepatocellular carcinoma Camk2n1 , Hdac4 Hepatomegaly Camk2a hereditary breast ovarian cancer syndrome Hdac5 Hereditary Leiomyomatosis and Renal Cell Cancer Ryr2 Hereditary Neoplastic Syndromes Camk2a , Gria1 , Ppp2ca hereditary sensory and autonomic neuropathy type 7 Scn5a hereditary spastic paraplegia 30 Hdac4 heroin dependence Gria1 , Grin2a high grade glioma Cacng2 , Camk2a , Camk2b Huntington's disease Grin2a , Grin2b Hyperalgesia Camk2a , Gria1 , Grin1 , Grin2a , Grin2b , Ppp2ca hyperhomocysteinemia Gria1 , Grin2a , Grin2b Hyperkinesis Gria1 Hyperphosphatemic Familial Tumoral Calcinosis 1 Cacna1c hyperprolinemia type 2 Camk2n1 hypertension Cacna1c , Cacnb2 hypertrophic cardiomyopathy Cacna1c , Cacnb2 , Pln , Ryr2 , Scn5a hypertrophic cardiomyopathy 1 Cacna1c , Ryr2 , Scn5a hypertrophic cardiomyopathy 18 Pln hypertrophic cardiomyopathy 4 Ryr2 Hyperventilation Camk2b Hypoalgesia Hdac4 hypoglycemia Cacna1c , Grin2b hypoparathyroidism-deafness-renal disease syndrome Cacnb2 Hypotension Gria1 , Grin2b Hypoxia Grin2b Imerslund-Grasbeck Syndrome Cacnb2 Immunodeficiency 68 Scn5a impotence Hdac4 Infant Death Ryr2 , Scn5a Inflammation Camk2a intellectual disability Cacna1c , Camk2a , Camk2b , Camk2g , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Lrrc7 , Pln , Syngap1 intrinsic cardiomyopathy Pln invasive ductal carcinoma Cacna1c , Dlg1 Japanese encephalitis Camk2n1 Joint Instability Cacna1c Joubert syndrome 1 Grin1 , Ppm1e Kleefstra syndrome 1 Grin1 Landau-Kleffner syndrome Grin2a , Grin2b Language Development Disorders Cacna1c , Grin1 , Grin2a Larsen syndrome Camk2a learning disability Gria1 Leber congenital amaurosis Ryr2 left ventricular noncompaction Ryr2 Left Ventricular Noncompaction 1 Scn5a Leigh disease Grin1 lissencephaly 10 Pln long QT syndrome Cacna1c , Cacnb2 , Calm1 , Calm2 , Calm3 , Ryr2 , Scn5a long QT syndrome 1 Cacna1c , Calm2 , Calm3 , Ryr2 , Scn5a long QT syndrome 14 Calm1 long QT syndrome 15 Calm2 long QT syndrome 16 Calm3 long QT syndrome 2 Scn5a Long QT Syndrome 2/3 Scn5a long QT syndrome 3 Scn5a Long QT Syndrome 3/6 Scn5a long QT syndrome 8 Cacna1c Lynch syndrome Calm2 Macrocephaly Grin1 major depressive disorder Cacna1c , Calm2 malignant astrocytoma Camk2g malignant mesothelioma Hdac4 , Ryr2 Marfanoid Mental Retardation Syndrome, Autosomal Syngap1 melanoma Grin2a MHC class I deficiency Syngap1 MHC class II deficiency Grin2a microcephaly Camk2b , Grin2a , Hdac4 , Pln middle cerebral artery infarction Camk2a , Grin1 , Hdac4 , Hdac5 migraine Scn5a mitochondrial metabolism disease Camk2a morphine dependence Gria1 , Grin1 , Grin2a morphine withdrawal syndrome Gria1 mulibrey nanism Ppm1e multiple intestinal atresia Calm2 multiple myeloma Hdac4 myocardial infarction Camk2d , Pln Myocardial Ischemia Camk2d , Ppp2ca , Ryr2 Myocardial Reperfusion Injury Pln myocardial stunning Pln nasopharynx carcinoma Grin2a neonatal abstinence syndrome Grin2a nephrotoxicity Camk2a Nerve Injuries Cacnb2 Nervous System Malformations Camk2b Nervous System Trauma Grin2b Neuralgia Grin2a Neurodevelopmental Disorder and Language Delay with or Without Structural Brain Abnormalities Ppp2ca NEURODEVELOPMENTAL DISORDER WITH CENTRAL HYPOTONIA AND DYSMORPHIC FACIES Hdac4 neurodevelopmental disorder with dysmorphic facies and distal limb anomalies Cacna1c neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures Cacna1c NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ARTHROGRYPOSIS, AND STRUCTURAL BRAIN ANOMALIES Grin2a Neurodevelopmental Disorder with or without Hyperkinetic Movements and Seizures, Autosomal Recessive Grin1 Neurodevelopmental Disorders Cacna1c , Cacng2 , Camk2a , Camk2b , Camk2d , Camk2g , Gria1 , Grin1 , Grin2a , Grin2b , Hdac4 , Ppp2ca , Syngap1 nicotine dependence Grin2b non-syndromic intellectual disability Gria1 Nonprogressive Heart Block Scn5a obesity Hdac4 Olfaction Disorders Gria1 oligodendroglioma Camk2b opioid abuse Grin1 , Grin2a , Grin2b oral squamous cell carcinoma Camk2n1 ovarian cancer Camk2n1 ovarian carcinoma Camk2n1 Ovarian Neoplasms Ppp1cc Pain Grin1 papillary thyroid carcinoma Camk2n1 parathyroid carcinoma Ryr2 Parkinson's disease Dlg1 , Ppp2ca Parkinson's disease 6 Camk2n1 Paroxysmal Ventricular Fibrillation Cacnb2 , Ryr2 , Scn5a phencyclidine abuse Calm1 , Calm2 , Camk2b phenylketonuria Grin2b placental insufficiency Grin1 , Grin2a , Grin2b pleomorphic xanthoastrocytoma Camk2b polycystic ovary syndrome Camk2d post-traumatic stress disorder Cacna1c , Grin2a pre-eclampsia Ryr2 Prehypertension Pln primary coenzyme Q10 deficiency 7 Grin1 primary hyperoxaluria type 1 Hdac4 primary immunodeficiency disease Cacna1c primary pulmonary hypertension Hdac4 , Hdac5 progressive familial heart block Scn5a Progressive Familial Heart Block Type I Scn5a progressive familial heart block type IA Scn5a prostate adenocarcinoma Camk2n1 prostate cancer Camk2n1 , Grin1 , Ppp2ca proteasome-associated autoinflammatory syndrome 1 Syngap1 Psychomotor Agitation Cacna1c psychotic disorder Grin1 ptosis Syngap1 pulmonary hypertension Hdac4 , Hdac5 , Ryr2 pulmonary valve stenosis Cacna1c pyridoxine-dependent epilepsy Grin2a rabies Camk2n1 Rafiq syndrome Grin1 renovascular hypertension Camk2d Reperfusion Injury Gria1 , Grin2a , Grin2b restrictive cardiomyopathy Cacna1c retinal degeneration Hdac4 retinitis pigmentosa Grin2b Right Ventricular Hypertrophy Hdac5 Romano-Ward Syndrome Cacna1c , Scn5a salt and pepper syndrome Syngap1 schizoaffective disorder Gria1 schizophrenia Cacna1c , Camk2b , Dlg1 , Grin1 , Grin2a , Grin2b , Syngap1 sciatic neuropathy Grin1 , Grin2b Sepsis Grin2a , Hdac4 sexual health disorder Gria1 short QT syndrome Cacna1c , Cacnb2 sick sinus syndrome Scn5a Sick Sinus Syndrome 1, Autosomal Recessive Scn5a sinoatrial node disease Scn5a Sleep Deprivation Grin2b speech disorder Grin2a Spinal Cord Injuries Ppp1cc spinal muscular atrophy Hdac4 status epilepticus Gria1 , Grin1 , Grin2a Stroke Hdac4 substance-induced psychosis Camk2b Sudden Cardiac Death Cacna1c , Pln , Ryr2 , Scn5a Sudden Death Cacna1c , Cacnb2 , Ryr2 , Scn5a sudden infant death syndrome Calm2 , Scn5a Sudden Unexpected Nocturnal Death Syndrome Cacna1c , Cacnb2 , Scn5a Supraventricular Tachycardia Cacnb2 Syncope Ryr2 , Scn5a syndromic intellectual disability Hdac4 systemic scleroderma Hdac5 Tachycardia Ryr2 temporal lobe epilepsy Grin2b Timothy syndrome Cacna1c Tinnitus Grin2a Torsades de Pointes Scn5a transient cerebral ischemia Camk2a , Grin2a , Grin2b traumatic brain injury Gria1 Tremor Cacna1c , Pln trigeminal neuralgia Grin1 tuberous sclerosis 1 Grin1 type 2 diabetes mellitus Calm1 , Pln , Ppp2ca urinary bladder cancer Hdac4 vascular dementia Grin1 , Grin2a , Grin2b Ventricular Dysfunction, Left Pln Ventricular Fibrillation Cacnb2 , Ryr2 , Scn5a Ventricular Fibrillation, Paroxysmal Familial, 1 Cacna1c , Ryr2 , Scn5a Ventricular Tachycardia Cacna1c , Cacnb2 , Ryr2 , Scn5a Visceral Heterotaxy 4, Autosomal Scn5a visual epilepsy Gria1 , Hdac4 Walker-Warburg syndrome Calm3 Weight Gain Calm1 Wilson disease Camk2a withdrawal disorder Gria1 , Grin2a , Grin2b Wolff-Parkinson-White syndrome Cacna1c , Ryr2 , Scn5a